← Back to Influence Map
Entity DossierOrganization
AMGEN USA, INC.
CA · US
Biotech company that discovers, develops, manufactures and delivers human theraputics
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$2,200,000
Connections
11
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
TAXTaxation/Internal Revenue Code
$2.3MMMMMedicare/Medicaid
$1.7MCPTCopyright/Patent/Trademark
$1.4MBUDBudget/Appropriations
$1.1MMEDMedical/Disease Research
$1.0MPHAPharmacy
$720KTRDTrade
$720KHCRHealth Issues
$100KLobbying Firms Retained
FORBES-TATE$1.0M
MARSHALL & POPP, LLC$720K
ACG ADVOCACY$700K
OGR$700K
AKIN GUMP STRAUSS HAUER & FELD$700K
Bills Referenced in Lobbying Filings
H.R. 5376
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | FORBES-TATE | Hired FORBES-TATE to lobby on Inflation Reduction Act - Energy | Source |
| Employed by | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 2nd Quarter (Apr 1 - June 30), reported amount $60,000 | Source |
| Lobbied for | Inflation Reduction Act - Energy Provisions (H.R.5376) | LDA filing: lobbied on Inflation Reduction Act - Energy, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Lobbied for | Inflation Reduction Act - Drug Pricing Provisions (H.R.5376) | LDA filing: lobbied on IRA Drug Pricing Provisions, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Employed by | OGR | Hired OGR to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | ACG ADVOCACY | Hired ACG ADVOCACY to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | AKIN GUMP STRAUSS HAUER & FELD | Hired AKIN GUMP STRAUSS HAUER & FELD to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Parent of | HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) | Horizon Therapeutics was acquired by Amgen in 2023 | Source |
| Parent of | HORIZON THERAPEUTICS | Horizon Therapeutics was acquired by Amgen in 2023 | Source |